| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $31.90M | - | |
| VP | 113.7K | $9.21M | -10,462 | |
| CFO | 90.3K | $7.31M | - | |
| Other | 80.1K | $6.49M | - | |
| VP | 79.1K | $6.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | Svoronos Dawn | Director | Sell | 506 | $56.96 | $28,819.74 | -1.8% | |
| Feb 1, 2021 | Hill Emily Luisa62 | Chief Financial Officer | Sell | 541 | $56.96 | $30,813.20 | -2.3% | |
| Feb 1, 2021 | Boulding Mark Elliott55 | Exec. VP And CLO | Sell | 778 | $56.96 | $44,311.77 | -1.6% | |
| Feb 1, 2021 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 1,001 | $56.96 | $57,012.96 | -2.6% | |
| Feb 1, 2021 | Pauwels Eric62 | Chief Business Officer | Sell | 362 | $56.96 | $20,618.07 | -1.0% | |
| Feb 1, 2021 | Peltz Stuart Walter57 | Chief Executive Officer | Sell | 2,251 | $56.96 | $128,207.96 | -2.3% | |
| Jan 25, 2021 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 541 | $63.15 | $34,165.63 | -12.6% | |
| Jan 25, 2021 | Hill Emily Luisa62 | Chief Financial Officer | Sell | 275 | $62.05 | $17,064.85 | -1.1% | |
| Jan 25, 2021 | Pauwels Eric62 | Chief Business Officer | Sell | 431 | $62.05 | $26,745.27 | -1.2% | |
| Jan 25, 2021 | Peltz Stuart Walter57 | Chief Executive Officer | Sell | 350 | $62.05 | $21,718.90 | -2.2% |